Drug Pipeline

Macitentan 75 mg Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Phase 3
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT05179876
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing…		 date change Completion pushed: 2029-03-30 -> 2030-09-30
Active Studies by Phase
Phase 3
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05179876 A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing… Hypertension, Pulmonary Recruiting
NCT04273945 Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With… Pulmonary Arterial Hypertension Active, Not Recruiting
Early Phase 1
NCT07392281 Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina Non-Coronary Obstructive Angina Recruiting
Sponsors Running Macitentan 75 mg Trials
Actelion (2) China-Japan Friendship Hospital (1)
Disease Areas
Hypertension (2)
Get alerts when Macitentan 75 mg trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free